Digital therapeutics and blockchain clinical trial systems for regulated healthcare
SUSMED develops treatment applications and clinical trial infrastructure for regulated healthcare, with a technical foundation spanning mobile (Kotlin, Swift), backend (Python, Go, Firebase), and blockchain (Hyperledger Fabric). The company is security-focused—three dedicated security roles, with pain points centered on compliance, access control, and data privacy—reflecting the operational burden of handling sensitive patient information at scale.
SUSMED is a digital therapeutics (DTx) company founded in 2015 and headquartered in Tokyo. The core business spans three areas: developing treatment applications for clinical use, providing a co-development platform for therapeutic apps, and building blockchain-based clinical trial systems. The company also offers medical data analytics and statistical consulting. Active projects include ePRO (electronic patient-reported outcome) systems, clinical trial efficiency tools, and hospital-side web applications. With 11–50 employees distributed across engineering, sales, security, data, and healthcare roles, SUSMED operates as a public company in Japan.
Mobile (Kotlin, Swift), backend (Python, Go, Firebase), infrastructure (AWS, GCP, Docker, Terraform), blockchain (Hyperledger Fabric), frontend (Vue, Bootstrap, JavaScript), and security tools (Nessus, OWASP ZAP).
ePRO system development, clinical trial efficiency tools, treatment app development, hospital-side web apps, and a blockchain-based clinical trial system. Active security strategy implementation and DTx clinical development also underway.
Other companies in the same industry, closest in size